Patient satisfaction with 6-monthly versus 3-monthly paliperidone palmitate long-acting injectable for schizophrenia treatment – results from a phase-3, randomised, noninferiority study
| Autor: | Milz, R., Desai, P., Sanga, P., Rozjabek, H., Keenan, A., Wang, S., Pelayo-Terán, J.M., Gopal, S. |
|---|---|
| Zdroj: | In Neuroscience Applied 2022 1 Supplement 2 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|